Aura Biosciences Inc (AURA)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-05-20 | 2025-05-16 | B Purchase | Non-Executive Director |
20,000
+13.7%
4.90USD 98,000 |
20,000 +13.7% | 4.90 | USD 98,000 | |
| 2025-05-20 | 2025-05-16 | S Sale |
See Remarks Officer |
1,519
-2.6%
5.15USD 7,823 |
1,519 -2.6% | 5.15 | USD 7,823 | |
| 2025-05-20 | 2025-05-16 | B Purchase |
See Remarks Officer |
50,000
+591.6%
4.90USD 245,000 |
50,000 +591.6% | 4.90 | USD 245,000 | |
| 2025-04-16 | 2025-04-16 | S Sale |
Senior Vice President, Finance Officer |
897
-1.1%
5.49USD 4,925 |
897 -1.1% | 5.49 | USD 4,925 | |
| 2025-04-16 | 2025-04-16 | S Sale |
See Remarks Officer |
7,162
-3.8%
5.49USD 39,319 |
7,162 -3.8% | 5.49 | USD 39,319 | |
| 2025-02-18 | 2025-02-18 | S Sale |
Chief Technology Officer Officer |
2,151
-1.0%
7.75USD 16,670 |
2,151 -1.0% | 7.75 | USD 16,670 | |
| 2025-02-18 | 2025-02-18 | S Sale |
Chief Medical Officer Officer |
2,534
-0.9%
7.75USD 19,639 |
2,534 -0.9% | 7.75 | USD 19,639 | |
| 2025-02-18 | 2025-02-18 | S Sale |
See Remarks Executive Director |
20,221
-4.0%
7.75USD 156,796 |
20,221 -4.0% | 7.75 | USD 156,796 | |
| 2025-02-18 | 2025-02-18 | S Sale |
Senior Vice President, Finance Officer |
1,404
-1.7%
7.75USD 10,881 |
1,404 -1.7% | 7.75 | USD 10,881 | |
| 2025-01-21 | 2025-01-21 | S Sale |
See Remarks Executive Director |
15,955
-5.0%
7.67USD 122,381 |
15,955 -5.0% | 7.67 | USD 122,381 | |
| 2025-01-21 | 2025-01-21 | S Sale |
Vice President, Finance Officer |
1,001
-2.5%
7.67USD 7,679 |
1,001 -2.5% | 7.67 | USD 7,679 | |
| 2024-11-18 | 2024-11-18 | S Sale |
Chief Medical Officer Officer |
11,822
-7.2%
9.36USD 110,663 |
11,822 -7.2% | 9.36 | USD 110,663 | |
| 2024-10-29 | 2024-10-29 | S Sale |
See Remarks Executive Director |
9,200
-2.8%
10.74USD 98,788 |
9,200 -2.8% | 10.74 | USD 98,788 | |
| 2024-10-29 | 2024-10-29 | S Sale |
Vice President, Finance Officer |
553
-1.4%
10.74USD 5,938 |
553 -1.4% | 10.74 | USD 5,938 | |
| 2024-10-21 | 2024-10-18 | PS Planned sale |
Chief Financial Officer Officer |
25,131
-15.8%
12.03USD 302,361 |
25,131 -15.8% | 12.03 | USD 302,361 | |
| 2024-10-18 | 2024-10-18 | PS Planned sale |
See Remarks Executive Director |
24,992
-7.0%
12.04USD 300,839 |
24,992 -7.0% | 12.04 | USD 300,839 | |
| 2024-10-16 | 2024-10-16 | S Sale |
Chief Technology Officer Officer |
7,383
-5.7%
9.85USD 72,723 |
7,383 -5.7% | 9.85 | USD 72,723 | |
| 2024-01-24 | 2024-01-23 | S Sale |
Chief Financial Officer Officer |
6,609
-9.5%
7.64USD 50,521 |
6,609 -9.5% | 7.64 | USD 50,521 | |
| 2024-01-24 | 2024-01-23 | S Sale |
See Remarks Executive Director |
15,853
-8.9%
7.64USD 121,141 |
15,853 -8.9% | 7.64 | USD 121,141 | |
| 2023-11-09 | 2023-11-09 | B Purchase |
Matrix Capital Management Company, LP Large shareholder |
1,560,000
+29.1%
9.00USD 14,040,000 |
1,560,000 +29.1% | 9.00 | USD 14,040,000 |